CN Stock MarketDetailed Quotes

002589 Realcan Pharmaceutical Group

Watchlist

Market Closed Jan 17 15:00 CST

4.20BMarket Cap103.33P/E (TTM)

Realcan Pharmaceutical Group Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Apr 30, 2019	2019/Q1	8.742B / 7.504B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 30, 20192019/Q18.742B / 7.504B--

Ruikang Pharmaceutical: Report for the third quarter of 2024

Oct 31, 2024 00:00

Ruikang Pharmaceutical: 2024 Semi-Annual Report Summary

Aug 27, 2024 00:00

Ruikang Pharmaceutical: 2024 Semi-Annual Report

Aug 27, 2024 00:00

Realcan Pharmaceutical Group: 2024 First Quarter Report

Apr 30, 2024 00:00

Overall

No Data